Toll Free: 1-888-928-9744
Published: Dec, 2015 | Pages:
27 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Recepta Biopharma S.A. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Recepta Biopharma S.A. - Product Pipeline Review - 2015', provides an overview of the Recepta Biopharma S.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Recepta Biopharma S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Recepta Biopharma S.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Recepta Biopharma S.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Recepta Biopharma S.A.'s pipeline products Reasons To Buy - Evaluate Recepta Biopharma S.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Recepta Biopharma S.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Recepta Biopharma S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Recepta Biopharma S.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Recepta Biopharma S.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Recepta Biopharma S.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Recepta Biopharma S.A. Snapshot 5 Recepta Biopharma S.A. Overview 5 Key Information 5 Key Facts 5 Recepta Biopharma S.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Recepta Biopharma S.A. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Recepta Biopharma S.A. - Pipeline Products Glance 12 Recepta Biopharma S.A. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Recepta Biopharma S.A. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Recepta Biopharma S.A. - Drug Profiles 14 RebmAb-100 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 RebmAb-200 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 RebmAb-500 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 RebPep-100 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 RebPep-101 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Recepta Biopharma S.A. - Pipeline Analysis 20 Recepta Biopharma S.A. - Pipeline Products by Target 20 Recepta Biopharma S.A. - Pipeline Products by Route of Administration 21 Recepta Biopharma S.A. - Pipeline Products by Molecule Type 22 Recepta Biopharma S.A. - Pipeline Products by Mechanism of Action 23 Recepta Biopharma S.A. - Dormant Projects 24 Recepta Biopharma S.A. - Locations And Subsidiaries 25 Head Office 25 Appendix 26 Methodology 26 Coverage 26 Secondary Research 26 Primary Research 26 Expert Panel Validation 26 Contact Us 26 Disclaimer 27
List of Tables
Recepta Biopharma S.A., Key Information 5 Recepta Biopharma S.A., Key Facts 5 Recepta Biopharma S.A. - Pipeline by Indication, 2015 7 Recepta Biopharma S.A. - Pipeline by Stage of Development, 2015 8 Recepta Biopharma S.A. - Monotherapy Products in Pipeline, 2015 9 Recepta Biopharma S.A. - Partnered Products in Pipeline, 2015 10 Recepta Biopharma S.A. - Partnered Products/ Combination Treatment Modalities, 2015 11 Recepta Biopharma S.A. - Phase II, 2015 12 Recepta Biopharma S.A. - Preclinical, 2015 13 Recepta Biopharma S.A. - Pipeline by Target, 2015 20 Recepta Biopharma S.A. - Pipeline by Route of Administration, 2015 21 Recepta Biopharma S.A. - Pipeline by Molecule Type, 2015 22 Recepta Biopharma S.A. - Pipeline Products by Mechanism of Action, 2015 23 Recepta Biopharma S.A. - Dormant Developmental Projects,2015 24
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.